Skip to main content


Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

  • Falk Roeder1, 2Email author,
  • Carmen Timke1, 2,
  • Ladan Saleh-Ebrahimi1, 2,
  • Lutz Schneider3,
  • Thilo Hackert3,
  • Werner Hartwig3,
  • Annette Kopp-Schneider4,
  • Frank W Hensley2,
  • Markus W Buechler3,
  • Juergen Debus1, 2,
  • Peter E Huber1, 2 and
  • Jens Werner3
Contributed equally
BMC Cancer201212:112

DOI: 10.1186/1471-2407-12-112

Received: 20 January 2012

Accepted: 23 March 2012

Published: 23 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
20 Jan 2012 Submitted Original manuscript
3 Mar 2012 Reviewed Reviewer Report - Dirk Vordermark
Resubmission - Version 2
Submitted Manuscript version 2
23 Mar 2012 Editorially accepted
23 Mar 2012 Article published 10.1186/1471-2407-12-112

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ)
Department of Radiation Oncology, University of Heidelberg
Department of Surgery, University of Heidelberg
Department of Biostatistics, German Cancer Research Center (DKFZ)